Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.0103448275862071 -0.0528735632183909 -0.042528735632184 -0.1
Stock impact report

FDA clears Sonoma Pharma's Loyon Skin Descaler; shares ahead 16% premarket [Seeking Alpha]

Sonoma Pharmaceuticals, Inc. (SNOA) 
Last sonoma pharmaceuticals, inc. earnings: 2/14 05:13 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.sonomapharma.com
Company Research Source: Seeking Alpha
Thinly traded nano cap Sonoma Pharmaceuticals (NASDAQ: SNOA ) perks up  % premarket on light volume in response to its announcement that it has received 510(k) clearance from the FDA for its Loyon Skin Descaler to manage skin scaling experienced with a range of dermatoses. The topically applied product is a patented combination of the dry emollient Cetiol CC and the medical silicone dimethicone. U.S. market launch will commence this summer through the company's IntraDerm Pharmaceuticals direct salesforce. Now read: Amgen: A Compelling Price On The Latest Dip » Show less Read more
Impact Snapshot
Event Time:
SNOA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
SNOA alerts

from News Quantified
Opt-in for
SNOA alerts

from News Quantified